|
National Stock Number(NSN): 6505-01-152-4626 (6505011524626, 011524626)
| NIIN: |
01-152-4626 |
Item Name: |
CHLORDIAZEPOXIDE HYDROCHLORIDE CAPSULES |
INC: |
30795
|
| FSC: |
6505
|
Assignment Date: |
May-03-1983 |
CRIT: |
X |
IIG: |
30795 |
| ISC: |
5 |
Date Standardized: |
May-03-1983 |
HMIC: |
P |
DODIC: |
|
| NSC: |
4 |
Cancellation Date: |
Oct-22-2024 |
PMIC: |
U |
FIIG: |
A510U0 |
| ESD: |
|
Schedule B: |
3004.49.0020 |
DEMIL: |
A |
DEMIL INT: |
1 |
| TIIC: |
1 |
Originator: |
97 |
ADPEC: |
|
RPDMRC: |
|
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
NDC00005-3748-62 |
06404
|
AMERICAN CYANAMID CO LEDERLE LABORATORIES DIV |
H |
5 |
9 |
6 |
54 |
|
B |
|
|
|
|
|
NDC00781-2080-01 |
59043
|
GENEVA PHARMACEUTICALS INC |
H |
3 |
2 |
4 |
54 |
|
|
|
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AKJA |
ACTIVE MEDICAMENT MEDICINAL STRENGTH |
5.000 MILLIGRAMS CHLORDIAZEPOXIDE HYDROCHLORIDE ACTIVE INGREDIENT |
| CQCT |
PRIMARY CONTAINER TYPE |
BOTTLE |
| CQLS |
CAPSULE CONTENT FORM |
ANY ACCEPTABLE |
| CSGS |
ADMINISTRATION |
ORAL |
| CYLZ |
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY |
100.000 |
| MDES |
MEDICAL DESIGNATION AND GRADE |
UNITED STATES PHARMACOPEIA |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| V540 |
|
Aug-01-1993 |
0 |
0 |
|
|
54 |
54 |
|